We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
- Authors
Reardon, David A; Akabani, Gamal; Coleman, R Edward; Friedman, Allan H; Friedman, Henry S; Herndon, James E, 2nd; McLendon, Roger E; Pegram, Charles N; Provenzale, James M; Quinn, Jennifer A; Rich, Jeremy N; Vredenburgh, James J; Desjardins, Annick; Gururangan, Sridharan; Badruddoja, Michael; Dowell, Jeanette M; Wong, Terence Z; Zhao, Xiao-Guang; Zalutsky, Michael R; Bigner, Darell D
- Abstract
To assess the efficacy and toxicity of intraresection cavity iodine-131-labeled murine antitenascin monoclonal antibody 81C6 (131I-m81C6) among recurrent malignant brain tumor patients.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 1, p115
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.03.4082